Page last updated: 2024-11-02

pindolol and Depressive Disorder, Treatment-Resistant

pindolol has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Zhou, X1
Zhu, D1
Chen, J1
Qin, B1
Zhang, Y1
Wang, X1
Yang, D1
Meng, H1
Luo, Q1
Xie, P1

Reviews

1 review available for pindolol and Depressive Disorder, Treatment-Resistant

ArticleYear
Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Human psychopharmacology, 2015, Volume: 30, Issue:3

    Topics: Adult; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Humans; Pindolol; Psychi

2015